Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Viral Vectors and Plasmid DNA Manufacturing
Revenue, means the sales value of Viral Vectors and Plasmid DNA Manufacturing
This report studies sales (consumption) of Viral Vectors and Plasmid DNA Manufacturing in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Aldevron
Eurogentec
Richter-Helm
BioReliance (A Part of SAFC Commercial)
Biovian
Brammer Bio
Cell and Gene Therapy Catapult
Cobra Biologics
FinVector
FUJIFILM Diosynth Biotechnologies
Lonza
MassBiologics
MolMed
Oxford BioMedica
Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
Spark Therapeutics
uniQure
ViGene Biosciences
Wuxi AppTec
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Plasmid DNA
Viral Vectors
Non-Viral Vectors
Split by application, this report focuses on sales, market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing in each application, can be divided into
Cancers
Inherited Disorders
Viral Infections
Others
Europe Viral Vectors and Plasmid DNA Manufacturing Market Report 2017
1 Viral Vectors and Plasmid DNA Manufacturing Overview
1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Classification of Viral Vectors and Plasmid DNA Manufacturing
1.2.1 Plasmid DNA
1.2.2 Viral Vectors
1.2.3 Non-Viral Vectors
1.3 Application of Viral Vectors and Plasmid DNA Manufacturing
1.3.1 Cancers
1.3.2 Inherited Disorders
1.3.3 Viral Infections
1.3.4 Others
1.4 Viral Vectors and Plasmid DNA Manufacturing Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Viral Vectors and Plasmid DNA Manufacturing (2012-2022)
1.5.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2022)
1.5.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
2 Europe Viral Vectors and Plasmid DNA Manufacturing by Manufacturers, Type and Application
2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers
2.1.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Type
2.2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type (2012-2017)
2.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2012-2017)
2.3 Europe Viral Vectors and Plasmid DNA Manufacturing (Volume and Value) by Countries
2.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Countries (2012-2017)
2.4 Europe Viral Vectors and Plasmid DNA Manufacturing (Volume) by Application
3 Germany Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
3.1 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
3.1.1 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
3.1.2 Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
3.1.3 Germany Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
3.2 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers
3.3 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
3.4 Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
4 France Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
4.1 France Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
4.1.1 France Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
4.1.2 France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
4.1.4 France Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
4.2 France Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers
4.3 France Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
4.4 France Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
5 UK Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
5.1 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
5.1.1 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
5.1.2 UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
5.1.5 UK Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
5.2 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers
5.3 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
5.4 UK Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
6 Russia Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
6.1 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
6.1.1 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
6.1.2 Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
6.1.6 Russia Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
6.2 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers
6.3 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
6.4 Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
7 Italy Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
7.1 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
7.1.1 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
7.1.2 Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
7.1.7 Italy Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
7.2 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers
7.3 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
7.4 Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
8 Spain Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
8.1 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
8.1.1 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
8.1.2 Spain Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
8.1.8 Spain Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
8.2 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers
8.3 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
8.4 Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
9 Benelux Viral Vectors and Plasmid DNA Manufacturing (Volume, Value and Sales Price)
9.1 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Value (2012-2017)
9.1.1 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
9.1.2 Benelux Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
9.2 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Manufacturers
9.3 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type
9.4 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application
10 Europe Viral Vectors and Plasmid DNA Manufacturing Manufacturers Analysis
10.1 Aldevron
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.1.2.1 Plasmid DNA
10.1.2.2 Viral Vectors
10.1.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Eurogentec
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.2.2.1 Plasmid DNA
10.2.2.2 Viral Vectors
10.2.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Richter-Helm
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.3.2.1 Plasmid DNA
10.3.2.2 Viral Vectors
10.3.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 BioReliance (A Part of SAFC Commercial)
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.4.2.1 Plasmid DNA
10.4.2.2 Viral Vectors
10.4.3 BioReliance (A Part of SAFC Commercial) Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Biovian
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.5.2.1 Plasmid DNA
10.5.2.2 Viral Vectors
10.5.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Brammer Bio
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.6.2.1 Plasmid DNA
10.6.2.2 Viral Vectors
10.6.3 Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Cell and Gene Therapy Catapult
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.7.2.1 Plasmid DNA
10.7.2.2 Viral Vectors
10.7.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Cobra Biologics
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.8.2.1 Plasmid DNA
10.8.2.2 Viral Vectors
10.8.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 FinVector
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.9.2.1 Plasmid DNA
10.9.2.2 Viral Vectors
10.9.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 FUJIFILM Diosynth Biotechnologies
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Type, Application and Specification
10.10.2.1 Plasmid DNA
10.10.2.2 Viral Vectors
10.10.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Lonza
10.12 MassBiologics
10.13 MolMed
10.14 Oxford BioMedica
10.15 Sanofi (CEPiA, Sanofi Pasteur, Genzyme)
10.16 Spark Therapeutics
10.17 uniQure
10.18 ViGene Biosciences
10.19 Wuxi AppTec
11 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis
11.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022)
14.1 Germany Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)
14.2 France Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)
14.3 UK Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)
14.4 Russia Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)
14.5 Italy Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)
14.6 Spain Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)
14.7 Benelux Viral Vectors and Plasmid DNA Manufacturing Sales Forecast (2017-2022)
14.8 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Type (2017-2022)
14.9 Europe Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Viral Vectors and Plasmid DNA Manufacturing
Table Classification of Viral Vectors and Plasmid DNA Manufacturing
Figure Europe Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type in 2015
Figure Plasmid DNA Picture
Figure Viral Vectors Picture
Figure Non-Viral Vectors Picture
Table Application of Viral Vectors and Plasmid DNA Manufacturing
Figure Europe Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Application in 2015
Figure Cancers Examples
Figure Inherited Disorders Examples
Figure Viral Infections Examples
Figure Others Examples
Figure Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
Figure France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
Figure UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
Figure Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
Figure Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
Figure Spain Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2022)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2022)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales of Key Manufacturers (2015 and 2016)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Viral Vectors and Plasmid DNA Manufacturing Sales Share by Manufacturers
Figure 2016 Viral Vectors and Plasmid DNA Manufacturing Sales Share by Manufacturers
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Manufacturers (2015 and 2016)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers
Table 2016 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Manufacturers
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Type (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Share by Type (2012-2017)
Figure Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Type (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Type (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Type (2012-2017)
Figure Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Growth Rate by Type (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Countries (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Share by Countries (2012-2017)
Figure Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Countries (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Countries (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Viral Vectors and Plasmid DNA Manufacturing by Countries (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales and Market Share by Application (2012-2017)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Share by Application (2012-2017)
Figure Sales Market Share of Viral Vectors and Plasmid DNA Manufacturing by Application (2012-2017)
Figure Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
Figure Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
Figure Germany Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
Table Germany Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)
Table Germany Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)
Table Germany Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)
Table Germany Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)
Table Germany Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)
Table Germany Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)
Figure France Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
Figure France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
Figure France Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
Table France Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)
Table France Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)
Table France Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)
Table France Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)
Table France Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)
Table France Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)
Figure UK Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
Figure UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
Figure UK Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
Table UK Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)
Table UK Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)
Table UK Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)
Table UK Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)
Table UK Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)
Table UK Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)
Figure Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
Figure Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
Figure Russia Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
Table Russia Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)
Table Russia Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)
Table Russia Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)
Table Russia Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)
Table Russia Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)
Table Russia Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)
Figure Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
Figure Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
Figure Italy Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
Table Italy Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)
Table Italy Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)
Table Italy Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)
Table Italy Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)
Table Italy Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)
Table Italy Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)
Figure Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
Figure Spain Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
Figure Spain Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
Table Spain Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)
Table Spain Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)
Table Spain Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)
Table Spain Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)
Table Spain Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)
Table Spain Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)
Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate (2012-2017)
Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate (2012-2017)
Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Sales Price Trend (2012-2017)
Table Benelux Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2015 and 2016)
Table Benelux Viral Vectors and Plasmid DNA Manufacturing Market Share by Manufacturers (2015 and 2016)
Table Benelux Viral Vectors and Plasmid DNA Manufacturing Sales by Type (2015 and 2016)
Table Benelux Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2015 and 2016)
Table Benelux Viral Vectors and Plasmid DNA Manufacturing Sales by Application (2015 and 2016)
Table Benelux Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2015 and 2016)
Table Viral Vectors and Plasmid DNA Manufacturing Basic Information List
Table Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Aldevron Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Eurogentec Basic Information List
Table Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eurogentec Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Richter-Helm Basic Information List
Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table BioReliance (A Part of SAFC Commercial) Basic Information List
Table BioReliance (A Part of SAFC Commercial) Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table BioReliance (A Part of SAFC Commercial) Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Biovian Basic Information List
Table Biovian Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biovian Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Brammer Bio Basic Information List
Table Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Brammer Bio Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Cell and Gene Therapy Catapult Basic Information List
Table Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Cobra Biologics Basic Information List
Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table FinVector Basic Information List
Table FinVector Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table FinVector Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table FUJIFILM Diosynth Biotechnologies Basic Information List
Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales, Revenue, Price and Gross Margin (2012-2017)
Table FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Sales Market Share (2012-2017)
Table Lonza Basic Information List
Table MassBiologics Basic Information List
Table MolMed Basic Information List
Table Oxford BioMedica Basic Information List
Table Sanofi (CEPiA, Sanofi Pasteur, Genzyme) Basic Information List
Table Spark Therapeutics Basic Information List
Table uniQure Basic Information List
Table ViGene Biosciences Basic Information List
Table Wuxi AppTec Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral Vectors and Plasmid DNA Manufacturing
Figure Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing
Figure Viral Vectors and Plasmid DNA Manufacturing Industrial Chain Analysis
Table Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2015
Table Major Buyers of Viral Vectors and Plasmid DNA Manufacturing
Table Distributors/Traders List
Figure Germany Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)
Figure Germany Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
Figure France Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)
Figure France Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
Figure UK Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)
Figure UK Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)
Figure Russia Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)
Figure Italy Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)
Figure Spain Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Viral Vectors and Plasmid DNA Manufacturing Revenue and Growth Rate Forecast (2017-2022)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Type (2017-2022)
Table Europe Viral Vectors and Plasmid DNA Manufacturing Sales Forecast by Application (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...